1.
Outcomes of Patients with Metastatic Melanoma Treated with Molecularly Targeted Agents in Phase I Clinical Trials
by Blanco Codesido, Montserrat
Oncology, 2011, Vol.81 (2), p.135-140

2.
Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases
by Frentzas, Sophia
Nature medicine, 2016, Vol.22 (11), p.1294-1302

3.
Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases
by Frentzas, Sophia
Nature medicine, 2016, Vol.22 (11), p.1294
